Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C

Hepatology

Volumn 63, Issue 6, 2016, Pages 2063-2064

  Shibata, Soichiro ^a   Umemura, Takeji ^a   Komatsu, Michiharu ^a   Tanaka, Eiji ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASUNAPREVIR; BILIRUBIN; DACLATASVIR; FRESH FROZEN PLASMA; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN E; LANINAMIVIR; PROTHROMBIN;

ADULT; ASCITES; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHRONIC HEPATITIS C; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG WITHDRAWAL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FEVER; HEPATITIS C VIRUS GENOTYPE 1; HUMAN; INFLUENZA; JAUNDICE; LETTER; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER TOXICITY; LYMPHOCYTE TRANSFORMATION TEST; MALAISE; MIDDLE AGED; NAUSEA AND VOMITING; PRIORITY JOURNAL; SIDE EFFECT; TOXIC HEPATITIS; TREATMENT RESPONSE; URINE COLOR;

EID: 84978217272     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28113     Document Type: Letter

References (2)

1. Fujii Y, Uchida Y, Mochida S. Drug-induced immunoallergic hepatitis during combination therapy with daclatasvir and asunaprevir. Hepatology 2015;61:400-401.
2. Kato Y, Kobayashi K, Hattori N, Takeuchi J, Ota G. Peripheral lymphocyte culture in the diagnosis of drug induced liver injury. Gastroenterol Jpn 1979;14:216-225.